Healthcare Services

Women’s Health Diagnostics Market Insights on Trends, Drivers, and Opportunities

April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Womens Health Diagnostics Market Be By 2030 Compared To Its 2026 Market Size?

The womens health diagnostics market size has experienced significant expansion in recent years. It is projected to grow from $36.88 billion in 2025 to $40.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to the increasing prevalence of women-specific diseases, the expansion of diagnostic infrastructure, a rising awareness of early screening benefits, an increase in laboratory testing services, and the adoption of imaging-based diagnostics.

The womens health diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $59.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this growth during the forecast period include a rising demand for tailored diagnostics, increased investments in precise testing technologies, the proliferation of home-based diagnostic solutions, the expanding integration of AI analytics, and a heightened emphasis on preventive screening initiatives. Key trends anticipated within the same period encompass the growing uptake of sophisticated imaging and testing technologies, an increase in the utilization of at-home diagnostic kits, the broadening application of AI in interpreting diagnostic results, the expansion of genetic and hormonal testing services, and a strengthened commitment to the early detection of diseases.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10725&type=smp

What Key Drivers Are Fueling The Growth Of The Womens Health Diagnostics Market?

The increasing need for personalized medicine is set to fuel the growth of the women’s health diagnostics market moving forward. Personalized medicine involves medical approaches that prevent, detect, or treat diseases by leveraging knowledge of an individual’s unique genes or proteins. This allows healthcare providers to devise treatment plans specifically customized to a woman’s distinct genetic, molecular, and clinical profile, potentially incorporating targeted therapies based on genetic markers or specific biomarkers. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, reported that the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, a rise from 6 approvals in 2022; the 2023 approvals also featured seven oncology therapies and three treatments for various other conditions. Thus, the escalating demand for personalized medicine is propelling the expansion of the women’s health diagnostics market.

What Segment Categories Shape The Womens Health Diagnostics Market Segment Landscape?

The womens health diagnostics market covered in this report is segmented –

1) By Type: Accessories And Consumables, Diagnostic Tests, Diagnostic Devices

2) By Application: Osteoporosis Testing, Ovarian Cancer Testing (OVC), Cervical Cancer Testing, Breast Cancer Testing, Pregnancy And Fertility Testing, Prenatal Genetic Screening And Carrier Testing, Infectious Disease Testing, Sexually Transmitted Diseases (STD) Testing, Ultrasound Tests

3) By End User: Hospitals And Clinics, Diagnostic And Imaging Centers, Homecare, Other End Users

Subsegments:

1) By Accessories And Consumables: Test Kits, Sample Collection Devices, Reagents, Control Materials

2) By Diagnostic Tests: Blood Tests, Imaging Tests, Genetic Tests, Hormonal Tests

3) By Diagnostic Devices: Imaging Devices, Invasive Diagnostic Devices, Non-Invasive Diagnostic Devices, Monitoring Devices

What Trends Are Influencing The Womens Health Diagnostics Market?

Leading companies in the women’s health diagnostics market are concentrating on product innovations, such as advanced ultrasound systems, to maintain their market presence. A premium ultrasound system is an intricate and sophisticated medical imaging device crafted to capture detailed, high-quality visuals of internal body structures. This type of premium ultrasound system is integrated into Samsung’s HERA platform, which is specifically designed for obstetrics and gynecology. For instance, in February 2023, Samsung’s digital radiography and ultrasound business, a US-based entity, launched the HERA W10 Elite, a cutting-edge women’s health ultrasound system. It is furnished with a collection of artificial intelligence (AI) tools and clinical applications, signifying a major enhancement in the diagnostic experience for women’s health. The HERA W10 Elite incorporates advanced functionalities like MV-Flow for depicting blood flow intensity, BiometryAssist for straightforward fetal growth parameter measurement, and accurate analytical abilities to support clinicians in their diagnoses.

Who Are The Companies Operating Across The Womens Health Diagnostics Market Value Chain?

Major companies operating in the womens health diagnostics market are Becton Dickinson And Company, F. Hoffmann-La Roche AG, General Electric Company, Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Abbott Laboratories, BioMérieux SA, Hologic Inc., PerkinElmer Inc., Alere Inc., Carestream Health Inc., Procter & Gamble Co., Trinity Biotech plc, Medgyn Products Inc., URIT Medical Electronic Co. Ltd, Sonic Healthcare Limited, Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Genomic Health Inc., Invitae Corporation, Natera Inc., QIAGEN N.V., Opko Health Inc., Sysmex Corporation, Exact Sciences Corporation, Foundation Medicine Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc.

Get The Full Womens Health Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

Which Region Dominates The Womens Health Diagnostics Market By Market Share?

North America was the largest region in the women’s health diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global women’s health diagnostics market report during the forecast period. The regions covered in the womens health diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Womens Health Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Womens Health Diagnostics Market 2026, By The Business Research Company

Womens Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

Clinical Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Womens Health Devices Market Report

https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795